← Back to Screener
Aspire Biopharma Holdings, Inc. Common Stock (ASBP)
Price$5.34
Momentum ScoreF
Favorite Metrics
Price vs S&P 500 (26W)-103.73%
Price vs S&P 500 (4W)-3.77%
VGM Score4.70
Market Capitalization$6.92M
All Metrics
Book Value / Share (Quarterly)$23.10
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-37.08
Price vs S&P 500 (YTD)-104.79%
EPS (TTM)$-168.87
10-Day Avg Trading Volume0.18M
EPS Excl Extra (TTM)$-168.87
EPS (Annual)$-491.29
ROI (Annual)22.79%
Gross Margin (Annual)-1.94%
Cash / Share (Quarterly)$34.97
ROA (Last FY)-1865.68%
EBITD / Share (TTM)$-74.55
Cash Flow / Share (Annual)$-41.80
P/B Ratio1.79x
P/B Ratio (Quarterly)1.34x
Net Interest Coverage (TTM)-4.14x
ROA (TTM)-397.99%
EPS Incl Extra (Annual)$-491.29
Current Ratio (Annual)0.17x
Quick Ratio (Quarterly)1.86x
3-Month Avg Trading Volume0.40M
52-Week Price Return-98.69%
P/S Ratio (Annual)1115.57x
Asset Turnover (Annual)0.00x
52-Week High$1050.00
EPS Excl Extra (Annual)$-491.29
26-Week Price Return-95.80%
Quick Ratio (Annual)0.13x
13-Week Price Return-86.41%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)2.26x
Enterprise Value$2.56M
Pretax Margin (Annual)-394852.42%
Cash / Share (Annual)$8.52
3-Month Return Std Dev226.25%
ROE (Last FY)22.80%
Net Interest Coverage (Annual)-1.06x
EPS Basic Excl Extra (Annual)$-491.29
Total Debt / Equity (Quarterly)0.39x
EPS Incl Extra (TTM)$-168.87
ROI (TTM)-60.04%
Revenue / Share (Annual)$0.12
Price vs S&P 500 (52W)-123.06%
Year-to-Date Return-96.63%
5-Day Price Return-10.40%
EPS Normalized (Annual)$-491.29
Net Profit Margin (Annual)-394852.42%
Month-to-Date Return-2.73%
EBITD / Share (Annual)$-395.65
Operating Margin (Annual)-317990.32%
EPS Basic Excl Extra (TTM)$-168.87
Price vs S&P 500 (13W)-94.67%
Beta0.16x
ROE (TTM)-83.31%
52-Week Low$3.31
mGradeF
vgmGradeF
Show chart for
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
ASBPAspire Biopharma Holdings, Inc. Common Stock | — | — | F | $5.34 |
| LLYEli Lilly & Co. | D | B | B | $1131.42 |
| JNJJohnson & Johnson | D | C | B | $232.77 |
| ABBVABBVIE INC. | D | C | C | $227.23 |
| MRKMerck & Co., Inc. | C | C | B | $120.79 |
| NVSNovartis AG | C | C | C | $149.16 |
| AZNAstraZeneca PLC | D | B | C | $185.95 |
| NVONovo-Nordisk A/S | B | B | B | $42.96 |
| ABTAbbott Laboratories | C | C | D | $91.07 |
| PFEPfizer Inc. | B | C | C | $26.04 |
| BMYBristol-Myers Squibb Co. | B | C | B | $57.27 |
About
Aspire Biopharma Holdings Inc develops nanotechnology-based drug delivery systems designed to improve medication absorption while reducing gastrointestinal exposure. The company's platform targets pain and inflammation management, with applications to opioid-related therapeutics. Its proprietary delivery mechanisms aim to enhance the efficacy and safety profiles of pharmaceutical compounds.